GSA Capital Partners LLP Purchases Shares of 3,926 Palomar Holdings, Inc. $PLMR

GSA Capital Partners LLP purchased a new position in Palomar Holdings, Inc. (NASDAQ:PLMR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 3,926 shares of the company’s stock, valued at approximately $496,000.

Other hedge funds have also recently modified their holdings of the company. Geneos Wealth Management Inc. bought a new position in shares of Palomar during the fourth quarter valued at about $32,000. Kestra Advisory Services LLC purchased a new position in Palomar during the 4th quarter valued at about $33,000. Rockefeller Capital Management L.P. increased its holdings in Palomar by 81.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock valued at $40,000 after purchasing an additional 132 shares during the period. Frazier Financial Advisors LLC bought a new position in Palomar during the 4th quarter valued at approximately $54,000. Finally, Parallel Advisors LLC raised its position in Palomar by 638.3% during the 1st quarter. Parallel Advisors LLC now owns 443 shares of the company’s stock valued at $53,000 after purchasing an additional 383 shares during the last quarter. Hedge funds and other institutional investors own 90.25% of the company’s stock.

Palomar Price Performance

NASDAQ PLMR opened at $130.09 on Friday. The business’s fifty day moving average price is $130.76 and its 200-day moving average price is $123.92. The stock has a market capitalization of $3.42 billion, a price-to-earnings ratio of 17.49 and a beta of 0.40. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.50 and a quick ratio of 0.50. Palomar Holdings, Inc. has a 1-year low of $100.81 and a 1-year high of $147.62.

Palomar (NASDAQ:PLMR) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $2.36 EPS for the quarter, topping the consensus estimate of $2.19 by $0.17. Palomar had a return on equity of 23.28% and a net margin of 18.61%.The company had revenue of $314.42 million during the quarter, compared to analyst estimates of $621.52 million. During the same quarter in the previous year, the company posted $1.76 earnings per share. On average, equities analysts predict that Palomar Holdings, Inc. will post 9.21 earnings per share for the current year.

Palomar Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 2nd. Shareholders of record on Wednesday, August 19th will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Wednesday, August 19th. Palomar’s dividend payout ratio (DPR) is presently 24.19%.

Insider Buying and Selling at Palomar

In other Palomar news, CEO Mac Armstrong sold 3,500 shares of the business’s stock in a transaction dated Tuesday, July 21st. The stock was sold at an average price of $137.26, for a total transaction of $480,410.00. Following the completion of the sale, the chief executive officer directly owned 325,888 shares in the company, valued at $44,731,386.88. The trade was a 1.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jonathan Knutzen sold 296 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $127.75, for a total transaction of $37,814.00. Following the completion of the transaction, the insider owned 28,250 shares in the company, valued at $3,608,937.50. This trade represents a 1.04% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 20,165 shares of company stock worth $2,680,993. 3.70% of the stock is owned by corporate insiders.

More Palomar News

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Strong premium growth and expansion in specialty insurance are expected to support Palomar’s earnings momentum. Analysts’ average price target of $162.75 and recent target increases reinforce the bullish view. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?
• Positive Sentiment: Dowling & Partners expressed a positive view of Palomar’s fiscal 2026 earnings outlook, adding to expectations for continued profit growth. DOWLING & PARTN Has Positive View of Palomar FY2026 Earnings
• Positive Sentiment: Palomar’s latest quarterly results provide fundamental support: earnings per share of $2.36 exceeded the $2.19 consensus estimate, while profitability and return on equity remained strong.
• Neutral Sentiment: Several insiders, including the president, CFO and Jonathan Knutzen, sold relatively small portions of their holdings to cover tax withholding on vested equity awards. Because the transactions were not discretionary sales, they are less negative than typical insider selling, though they may limit near-term sentiment.
• Neutral Sentiment: Palomar declared a quarterly dividend of $0.45, equivalent to $1.80 annually and a yield of approximately 1.4%, providing modest shareholder support.
• Negative Sentiment: Competitive pricing could reduce premium profitability, while a higher combined ratio would pressure underwriting margins. These risks may temper the market’s response to otherwise strong growth expectations. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on PLMR. Evercore set a $152.00 price objective on Palomar in a research report on Friday, July 10th. JPMorgan Chase & Co. lifted their price objective on Palomar from $150.00 to $167.00 and gave the company an “overweight” rating in a research report on Monday, July 20th. Weiss Ratings raised Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, June 18th. Zacks Research cut shares of Palomar from a “strong-buy” rating to a “hold” rating in a report on Friday, May 15th. Finally, Keefe, Bruyette & Woods upped their target price on shares of Palomar from $166.00 to $167.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $162.75.

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.